Bcl2L12 is an inhibitor of the activation of postmitochondrial effector caspases that is overexpressed in glioblastoma, playing an anti-apoptotic role; it features a dominion similar to BH3 in its structure, which interacts with Bcl-xL and Bcl2. The gene discussed is BCL2; the disease is glioblastoma.